Eupraxia Pharmaceuticals Secures $70 Million Through Public Offering to Accelerate Osteoarthritis Treatment Development
Adial Pharmaceuticals Soars: FDA's Positive Feedback Fuels Hope for Groundbreaking AUD Treatment
Harbour BioMed Welcomes Dr. Yajie Li as New Chief Medical Officer